Summary of incubation conditions for cytochrome P450 marker assays Assay conditions were as described under Materials and Methods. Results are means of two to four independent experiments. Control activity without inhibitor was set at 100%.
P450 | Reaction | Substrate Concentration | Control Inhibitor | Inhibitor Concentration | Residual Activity |
---|---|---|---|---|---|
μM | μM | % | |||
1A2 | 7-Ethoxycoumarin O-deethylation | 10 | Furafylline | 10 | 8.4 |
2A6 | Coumarin 7-hydroxylation | 200 | Diethyldithiocarbamate | 100 | 30.7 |
2B6 | Bupropion hydroxylation | 50 | Triethylenethiophosphoramide | 10 | 11.8 |
2C8 | Verapamil O-demethylation | 100 | Ketoconazole | 100 | N.D. |
2C9 | (S)-Mephenytoin N-demethylation | 10 | Sulfaphenazole | 10 | 34.7 |
2C19 | (S)-Mephenytoin 4'-hydroxylation | 200 | Ketoconazole | 100 | 41.7 |
2D6 | Propafenone 5-hydroxylation | 2 | Quinidine | 5 | 40.7 |
2E1 | 7-Ethoxycoumarin O-deethylation | 200 | Diethyldithiocarbamate | 1 | 1.2 |
3A4 | Verapamil N-demethylation | 100 | Ketoconazole | 100 | 18.2 |
N.D., not detectable.